1. Home
  2. ALXO vs LASE Comparison

ALXO vs LASE Comparison

Compare ALXO & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • LASE
  • Stock Information
  • Founded
  • ALXO 2015
  • LASE 2019
  • Country
  • ALXO United States
  • LASE United States
  • Employees
  • ALXO N/A
  • LASE N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • LASE Industrial Machinery/Components
  • Sector
  • ALXO Health Care
  • LASE Industrials
  • Exchange
  • ALXO Nasdaq
  • LASE Nasdaq
  • Market Cap
  • ALXO 24.0M
  • LASE 51.8M
  • IPO Year
  • ALXO 2020
  • LASE 2022
  • Fundamental
  • Price
  • ALXO $0.61
  • LASE $3.03
  • Analyst Decision
  • ALXO Strong Buy
  • LASE
  • Analyst Count
  • ALXO 6
  • LASE 0
  • Target Price
  • ALXO $3.30
  • LASE N/A
  • AVG Volume (30 Days)
  • ALXO 500.5K
  • LASE 470.8K
  • Earning Date
  • ALXO 08-07-2025
  • LASE 07-07-2025
  • Dividend Yield
  • ALXO N/A
  • LASE N/A
  • EPS Growth
  • ALXO N/A
  • LASE N/A
  • EPS
  • ALXO N/A
  • LASE N/A
  • Revenue
  • ALXO N/A
  • LASE $4,962,487.00
  • Revenue This Year
  • ALXO N/A
  • LASE N/A
  • Revenue Next Year
  • ALXO N/A
  • LASE N/A
  • P/E Ratio
  • ALXO N/A
  • LASE N/A
  • Revenue Growth
  • ALXO N/A
  • LASE 23.87
  • 52 Week Low
  • ALXO $0.40
  • LASE $1.58
  • 52 Week High
  • ALXO $6.08
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 61.99
  • LASE 48.89
  • Support Level
  • ALXO $0.44
  • LASE $2.90
  • Resistance Level
  • ALXO $0.64
  • LASE $3.08
  • Average True Range (ATR)
  • ALXO 0.04
  • LASE 0.37
  • MACD
  • ALXO 0.01
  • LASE -0.05
  • Stochastic Oscillator
  • ALXO 72.40
  • LASE 6.17

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: